Columbia Financial (CLBK)
(Delayed Data from NSDQ)
$16.84 USD
-0.05 (-0.30%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $16.81 -0.03 (-0.18%) 4:32 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Columbia Financial falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 422 | 340 | 309 | 327 | 293 |
Cost Of Goods | 125 | 28 | 29 | 55 | 62 |
Gross Profit | 297 | 312 | 280 | 272 | 231 |
Selling & Adminstrative & Depr. & Amort Expenses | 187 | 177 | 145 | 175 | 130 |
Income After Depreciation & Amortization | 111 | 135 | 135 | 97 | 101 |
Non-Operating Income | 1 | 3 | 1 | 2 | 3 |
Interest Expense | 64 | 15 | 8 | 19 | 27 |
Pretax Income | 46 | 117 | 126 | 76 | 71 |
Income Taxes | 10 | 31 | 34 | 19 | 16 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 36 | 86 | 92 | 58 | 55 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 36 | 86 | 92 | 58 | 55 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 132 | 157 | 153 | 108 | 108 |
Depreciation & Amortization (Cash Flow) | 21 | 22 | 18 | 11 | 7 |
Income After Depreciation & Amortization | 111 | 135 | 135 | 97 | 101 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 102.90 | 106.19 | 104.16 | 109.76 | 111.10 |
Diluted EPS Before Non-Recurring Items | 0.49 | 0.85 | 0.90 | 0.57 | 0.48 |
Diluted Net EPS (GAAP) | 0.35 | 0.81 | 0.88 | 0.52 | 0.49 |
Fiscal Year end for Columbia Financial falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 124.87 | 122.47 | 116.08 | 118.80 | 107.01 |
Cost Of Goods | NA | 49.83 | 48.42 | 43.43 | 35.92 |
Gross Profit | NA | 72.64 | 67.66 | 75.37 | 71.09 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 47.75 | 50.91 | 48.83 | 45.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 24.89 | 16.75 | 26.54 | 25.81 |
Non-Operating Income | NA | 0.69 | 0.02 | 0.33 | 0.01 |
Interest Expense | NA | 19.38 | 18.01 | 18.78 | 13.97 |
Pretax Income | NA | 4.82 | -1.28 | 7.43 | 11.84 |
Income Taxes | NA | 0.28 | -0.13 | 0.87 | 2.71 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 6.19 | 4.54 | -1.16 | 6.57 | 9.13 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.19 | 4.54 | -1.16 | 6.57 | 9.13 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 101.83 | 101.65 | 101.99 | 101.82 | 102.10 |
Diluted EPS Before Non-Recurring Items | 0.06 | 0.05 | 0.01 | 0.09 | 0.09 |
Diluted Net EPS (GAAP) | 0.06 | 0.04 | -0.01 | 0.06 | 0.09 |